Su Yin Lim Selected Research

Su Yin Lim Research Topics

Disease

15	Melanoma (Melanoma, Malignant) 01/2024 - 01/2017
14	Neoplasms (Cancer) 02/2024 - 02/2013
6	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2013
3	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 02/2013
3	Inflammation (Inflammations) 10/2011 - 10/2008
2	Colonic Neoplasms (Colon Cancer) 11/2019 - 05/2019
2	Atherosclerosis 09/2009 - 07/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2024
1	Uveal melanoma 02/2024
1	Inappropriate ADH Syndrome (SIADH) 12/2019
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 12/2019
1	Fever (Fevers) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Squamous Cell Carcinoma of Head and Neck 01/2017
1	Lewis Lung Carcinoma 08/2015
1	Multiple Sclerosis 04/2015
1	Infections 09/2009
1	Rheumatoid Arthritis 09/2009
1	Cystic Fibrosis (Mucoviscidosis) 09/2009
1	Acute Coronary Syndrome 07/2009
1	Atherosclerotic Plaque (Atheroma) 07/2009
1	Rupture 07/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2009

Drug/Important Bio-Agent (IBA)

8	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2017
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2017
3	CytokinesIBA 01/2023 - 07/2009
2	AntigensIBA 01/2023 - 11/2020
2	Programmed Cell Death 1 ReceptorIBA 05/2021 - 01/2018
2	trametinibIBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2017
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2017
2	Conditioned Culture MediaIBA 05/2019 - 08/2015
2	CCR2 ReceptorsIBA 05/2016 - 02/2013
1	Tyrosine Kinase InhibitorsIBA 02/2024
1	ripretinibIBA 02/2024
1	Protein Kinase CIBA 02/2024
1	Differentiation AntigensIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2021
1	HLA-DR Antigens (HLA-DR)IBA 05/2021
1	Histocompatibility Antigens Class IIBA 11/2020
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 10/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2019
1	Vasopressins (Vasopressin)IBA 12/2019
1	Detergents (Detergent)IBA 11/2019
1	Annexin A1IBA 11/2019
1	Laminin (Merosin)IBA 05/2019
1	laminin 10IBA 05/2019
1	Small Interfering RNA (siRNA)IBA 05/2019
1	dabrafenibIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Circulating Tumor DNAIBA 01/2018
1	InterferonsIBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Blood Proteins (Serum Proteins)IBA 01/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2017
1	Diphtheria ToxinIBA 08/2015
1	AngiopoietinsIBA 08/2015
1	A 7 (A-7)IBA 04/2015
1	IronIBA 04/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2011
1	Carrier Proteins (Binding Protein)IBA 07/2009
1	Matrix Metalloproteinases (MMPs)IBA 07/2009
1	C-Reactive ProteinIBA 07/2009
1	S100A12 ProteinIBA 07/2009

Therapy/Procedure

7	Therapeutics 02/2024 - 02/2013
7	Immunotherapy 01/2023 - 01/2017
1	Salvage Therapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2019
1	Adjuvant Chemoradiotherapy 01/2017
1	Chemoradiotherapy 01/2017
1	Percutaneous Coronary Intervention 07/2009